摩洛哥患者与差异化甲状腺癌的长期生存率
Hajar Tabiti1, Amal Guensi1,2, Karima Bendahhou3
1Laboratory of Cellular and Molecular Inflammatory, Degenerative and Oncologic Pathophysiology, Hassan II University Casablanca, Morocco.
Asian Pacific journal of cancer prevention : APJCP
|March 29, 2025
概括
这项研究发现,摩洛哥患有差异化甲状腺癌 (DTC) 的患者的生存率很好,与国际数据相似. 诸如男性性别,年龄较大和瘤特征等关键因素显著影响长期结果.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 公共卫生 公共卫生
背景情况:
- 卵泡起源的差异化甲状腺癌 (DTC) 通常具有良好的预后.
- 然而,整体存活率受到各种因素的影响.
- 这项研究专门研究了摩洛哥患者的生存率.
研究的目的:
- 分析毛囊差异化甲状腺癌 (DTC) 的五年和十年总生存率.
- 确定影响摩洛哥DTC患者生存的独立因素.
主要方法:
- 在2004年至2012年间诊断的1366名患者进行了回顾性队列研究.
- 用于计算生存率的卡普兰-梅尔方法.
- 用于根据各种因素比较生存率的Log-rank测试.
主要成果:
- 五年生存率为94%,十年生存率为91%.
- 降低存活率的因素包括男性性别,年龄>55,瘤大小>4厘米,血管入侵,淋巴结入侵,远程转移和晚期.
- 术后提升的铁球蛋白 (Tg) 和放射性治疗后的水平 (>10 ng/ml) 也与生存时间的减少有关.
结论:
- 摩洛哥DTC患者的整体生存率与国际文献一致.
- 患者人口统计学 (年龄,性别),瘤特征 (组织学,大小,入侵) 和治疗反应 (Tg水平,RAI疗法) 显著影响生存率.
- 疾病阶段和风险组是整体生存的关键决定因素.
相关概念视频
Cancer Survival Analysis
291
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
291
Actuarial Approach
39
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
39


